Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Bioventus Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- −4 vs. Q1 2022
- Shares held
- 34.0M
- +2.35M (+7.4%) vs. Q1 2022
- Total value
- $232.0M
- −$214.2M (−48.0%) vs. Q1 2022
- New holders
- 18
- 46 more added
- Sold out
- 22
- 23 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $509.4M |
| Q1 2026 | 157 | $466.4M |
| Q4 2025 | 148 | $373.3M |
| Q3 2025 | 135 | $328.9M |
| Q2 2025 | 134 | $320.3M |
| Q1 2025 | 144 | $427.0M |
| Q4 2024 | 151 | $477.8M |
| Q3 2024 | 138 | $537.1M |
| Q2 2024 | 103 | $222.2M |
| Q1 2024 | 84 | $178.0M |
| Q4 2023 | 80 | $175.4M |
| Q3 2023 | 67 | $108.9M |
| Q2 2023 | 66 | $92.6M |
| Q1 2023 | 71 | $33.4M |
| Q4 2022 | 85 | $81.9M |
| Q3 2022 | 94 | $245.9M |
| Q2 2022 | 98 | $232.0M |
| Q1 2022 | 105 | $447.0M |
| Q4 2021 | 98 | $451.6M |
| Q3 2021 | 69 | $351.8M |
| Q2 2021 | 53 | $364.5M |
| Q1 2021 | 45 | $334.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Bioventus Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dean Investment Associates, LLC | 0 | $0 | 0.00% | −62,573−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −43,339−100.0% | Sold out |
| Dean Capital Management | 0 | $0 | 0.00% | −42,595−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −28,017−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −25,152−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −23,200−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −20,774−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,406−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −11,357−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −10,440−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −7,183−100.0% | Sold out |
| State of Tennessee, Treasury Department | 0 | $0 | 0.00% | −5,660−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,194−100.0% | Sold out |
| RPg Family Wealth Advisory, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −330−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Covington Capital Management | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Northwest Investment Counselors, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |